Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy [0.03%]
冠状动脉钙化指导下的动脉初级预防策略的相关证据缺口分析
Michael J Blaha
Michael J Blaha
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model: A Secondary Analysis of FINEARTS-HF [0.03%]
FINEARTS-HF的二次分析：PREDICT-HFpEF模型评估心力衰竭和风险中的非奈酮作用
Kirsty McDowell,Kieran F Docherty,Ross T Campbell et al.
Kirsty McDowell et al.
Importance: Patients with heart failure (HF) and mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF) have a spectrum of risk, and the effect of therapies may vary by risk. ...
Simultaneous or Rapid Initiation of Combination Therapy for Heart Failure With Preserved Ejection Fraction [0.03%]
射血分数保留的心衰组合治疗的同步或快速启动疗法
Stephen J Greene,Javed Butler,Gregg C Fonarow
Stephen J Greene
Importance of Age and Sex in Carotid Artery Plaque Detection and Cardiovascular Disease Risk [0.03%]
年龄和性别在颈动脉斑块检测和心血管疾病风险评估中的重要性
Matthew C Tattersall,Spencer L Hansen,Robyn L McClelland et al.
Matthew C Tattersall et al.
Importance: Carotid artery plaque (CAP) is commonly encountered in clinical practice. Presence of CAP predicts future atherosclerotic cardiovascular disease (ASCVD) events; however, CAP prevalence increases with age, and ...
Published Erratum
JAMA cardiology. 2025 Mar 5. DOI:10.1001/jamacardio.2025.0396 2025
Alexander R Zheutlin,Anuj K Chokshi,John T Wilkins et al.
Alexander R Zheutlin et al.
Importance: Traditional risk factors, enhancing factors, and risk scores help clinicians assess atherosclerotic cardiovascular disease (ASCVD) risk for primary prevention. The latest cholesterol guidelines suggest measuri...
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy [0.03%]
缬沙坦与早期肥厚型心肌病的心脏重构：VANISH随机临床试验心脏磁共振成像子研究
John W Ostrominski,Brian L Claggett,Michael Jerosch-Herold et al.
John W Ostrominski et al.
Importance: Valsartan has been shown to attenuate phenotypic progression among individuals with early-stage sarcomeric hypertrophic cardiomyopathy (HCM). Myocardial tissue characterization by cardiac magnetic resonance (C...
Error in Results [0.03%]
结果中的错误
Published Erratum
JAMA cardiology. 2025 Feb 26. DOI:10.1001/jamacardio.2025.0076 2025
Gregg C Fonarow,Adrian F Hernandez,James E Udelson et al.
Gregg C Fonarow et al.
Somogy Varga,Asbjørn Steglich-Petersen
Somogy Varga